Vascular endothelial growth factor-C contributes to the development of skin inflammation in obese individuals, and intradermal injection of recombinant vascular endothelial growth factor-C enhances lymphangiogenesis and lymphatic function, leading to the suppression of cutaneous inflammation. Here, VEGFC is linked to dermatitis.